The global market for breast lesion localization devices is set for substantial growth, with sales estimated to reach USD 360.9 million in 2024 and expected to climb to USD 593.5 million by 2034. This growth represents a compound annual growth rate (CAGR) of 5.1% over the next decade, following a year-on-year increase of 5.2% from …